JAK2 and thyroid gland carcinoma: Insulin-like factors and leptin have been suggested to play vital roles in thyroid carcinoma growth, and they have been associated with the aggressiveness of PTC in obese patients by increasing insulin or insulin-like growth factor levels through the PI3K/AKT and JAK2-STAT3 signaling pathways [27–29].